Advertisement

Drug Distribution

  • Abialbon Paul
Chapter

Abstract

The process of drug movement after absorption into various body compartments like the interstitial space and the intracellular space is called drug distribution. Distribution is an important process which results in exposure of the target organ to the drug. The initial phase is highly influenced by the amount of blood flow to various organs and is responsible for the acute onset action of the drugs. The second phase is a slower phase where the drug equilibrates with the muscle, skin, and fat. The second phase can be responsible for the termination of action for some of the drugs. The cardiac output, local regional blood flow, alterations in capillary permeability, plasma protein binding, the local pH, and affinity to tissue proteins are some of the factors that influence drug distribution. Increase in plasma protein binding results in lower volume of distribution, longer duration of action, and slower onset of action. Plasma protein binding is responsible for displacement reactions and drug interactions. Excessive tissue protein binding can result in organ toxicities. To some extent, distribution can be quantified by the apparent volume of distribution. The volume of distribution helps us determine the loading dose of drugs which are required in emergency settings.

Keywords

Distribution Protein binding Volume of distribution Redistribution Drug displacement 

Bibliography

  1. Bohnert T, Gan L-S (2013) Plasma protein binding: from discovery to development. J Pharm Sci 102:2953–2994.  https://doi.org/10.1002/jps.23614CrossRefPubMedGoogle Scholar
  2. Kok-Yong S, Lawrence L (2015) Drug distribution and drug elimination. In: Ahmed TA (ed) Basic pharmacokinetic concepts and some clinical applications. InTech, Rijeka.  https://doi.org/10.5772/59929CrossRefGoogle Scholar
  3. Roberts DJ, Hall RI (2013) Drug absorption, distribution, metabolism and excretion considerations in critically ill adults. Expert Opin Drug Metab Toxicol 9:1067–1084.  https://doi.org/10.1517/17425255.2013.799137CrossRefPubMedGoogle Scholar
  4. Smith DA, Beaumont K, Maurer TS, Di L (2015) Volume of distribution in drug design. J Med Chem 58:5691–5698.  https://doi.org/10.1021/acs.jmedchem.5b00201CrossRefPubMedGoogle Scholar
  5. Vesell ES (1974) Relationship between drug distribution and therapeutic effects in man. Annu Rev Pharmacol 14:249–270.  https://doi.org/10.1146/annurev.pa.14.040174.001341CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Abialbon Paul
    • 1
  1. 1.Department of Pharmacology & Clinical SkillsMedical University of AmericasCharlestown, NevisSaint Kitts and Nevis

Personalised recommendations